tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TSE:BCT Stock Latest News

BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025
Company AnnouncementsBriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025
4d ago
BCTX
Promising Phase 2 Results and Safety Profile Support Buy Rating for BriaCell Therapeutics
PremiumRatings
Promising Phase 2 Results and Safety Profile Support Buy Rating for BriaCell Therapeutics
5d ago
BCTX
BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies
PremiumCompany Announcements
BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies
6d ago
BCTX
BriaCell reports overall survival, clinical benefit data at ASCO 2025
PremiumThe Fly
BriaCell reports overall survival, clinical benefit data at ASCO 2025
6d ago
BCTX
BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase
PremiumCompany Announcements
BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase
12d ago
BCTX
BriaCell Bria-OTS Phase 1/2 study clears safety evaluation
PremiumThe FlyBriaCell Bria-OTS Phase 1/2 study clears safety evaluation
12d ago
BCTX
BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment
Premium
Company Announcements
BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment
16d ago
BCTX
BriaCell announces presentation of survival, clinical benefit data at ASCO 2025
Premium
The Fly
BriaCell announces presentation of survival, clinical benefit data at ASCO 2025
16d ago
BCTX
BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results
PremiumCompany Announcements
BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results
19d ago
BCTX
BriaCell issues letter to shareholders
PremiumThe Fly
BriaCell issues letter to shareholders
19d ago
BCTX
BriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
PremiumCompany Announcements
BriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
1M ago
BCTX
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
PremiumThe Fly
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
1M ago
BCTX
BriaCell Therapeutics Closes $13.8 Million Public Offering
PremiumCompany AnnouncementsBriaCell Therapeutics Closes $13.8 Million Public Offering
1M ago
BCTX
BriaCell’s Breakthrough in Cancer Immunotherapy at AACR 2025
Premium
Company Announcements
BriaCell’s Breakthrough in Cancer Immunotherapy at AACR 2025
1M ago
BCTX
BriaCell presents data from Phase 2 study of Bria-IMT
Premium
The Fly
BriaCell presents data from Phase 2 study of Bria-IMT
1M ago
BCTX
BriaCell 3.07M share Secondary priced at $4.50
PremiumThe Fly
BriaCell 3.07M share Secondary priced at $4.50
1M ago
BCTX
BriaCell Therapeutics Announces $13.8 Million Public Offering
PremiumCompany Announcements
BriaCell Therapeutics Announces $13.8 Million Public Offering
1M ago
BCTX
BriaCell’s Bria-OTS Shows Promising Results in Metastatic Breast Cancer Study
PremiumCompany Announcements
BriaCell’s Bria-OTS Shows Promising Results in Metastatic Breast Cancer Study
2M ago
BCTX
BriaCell confirms 100% resolution of lung metastasis with Bria-OTS
PremiumThe Fly
BriaCell confirms 100% resolution of lung metastasis with Bria-OTS
2M ago
BCTX
BriaCell to Present Key Clinical Data at ASCO 2025
PremiumCompany AnnouncementsBriaCell to Present Key Clinical Data at ASCO 2025
2M ago
BCTX
BriaCell files to sell 2.33M common units
Premium
The Fly
BriaCell files to sell 2.33M common units
2M ago
BCTX
BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating
Premium
Ratings
BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating
2M ago
BCTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >